Home › Forums › Main Forum › Media & News › Surprise: Gilead’s hep C wonder Harvoni costs less in U.S. than
- This topic has 5 replies, 5 voices, and was last updated 8 years ago by
mgalbrai.
-
AuthorPosts
-
22 September 2016 at 3:25 am #23196
Now, we have some numbers that illustrate just how big Gilead’s discounts are–and how its U.S. hep C prices after those discounts compare with similar figures overseas.
Genotype 1A
ALT 473
AST 226
Virus Load 3,119,030
Results as of May-2016
5 week viral load/undetected as of 12/02/2016
Liver Biopsy Results from Feb 2013
Portal/Periportal chronic inflammation and mild interface hepatitis (Grade 2)
Focal Lobular chronic inflammation (Grade 1)
Portal/Periportal fibrosis (stage 1-2 trichrome and reticulin stains utilized)
Negative Iron stains.22 September 2016 at 4:27 am #23200The fundamental problem is that a 50% discount sounds great until you consider that the mark up is over 10,000%
The discount reduces that to a mere 5,000% and no matter which way you look at it $50,000 is a shit ton of cash for something that costs a few hundred dollars.
Gilead have been magnificent in reframing the arguments from:
1) “Greedy Pharma price gouging” to “Mean insurers refuse to pay”
2) “Prices are unaffordable” to “We give big discounts”
3) “Most of the world can’t get access” to “We have an access program for low income countries”These two links show part of their strategy:
YMMV
22 September 2016 at 4:29 am #23202Oh I agree. I wasn’t defending them. Thanks for the links.
Genotype 1A
ALT 473
AST 226
Virus Load 3,119,030
Results as of May-2016
5 week viral load/undetected as of 12/02/2016
Liver Biopsy Results from Feb 2013
Portal/Periportal chronic inflammation and mild interface hepatitis (Grade 2)
Focal Lobular chronic inflammation (Grade 1)
Portal/Periportal fibrosis (stage 1-2 trichrome and reticulin stains utilized)
Negative Iron stains.22 September 2016 at 5:42 am #23206Tommy wrote:Now, we have some numbers that illustrate just how big Gilead’s discounts are–and how its U.S. hep C prices after those discounts compare with similar figures overseas.
So are you paying the discount price of $50,000.00++ or going with GP2U Trials for $49,000 less money and same results? Big decision.
Contracted HCV 1980’s
Geno Type 1a
F3 ( doc says once treated I’ll be F2 maybe F1)
Meds shipped 6/17/2016 arrived early 7/2016Viral count – 3,471,080
4 week quantitative bloods: August 17, 2016. I have been diagnosed as <15 (told undetected)
8 week quantitative bloods: September 14th. I have been diagnosed as <15 (told undetected)
11 week PCR RNA Qualitative bloods: September 26th 2016 – Undetected
December 19th 2016: Cured!
Viral count: zero!!!
2018 viral count: still zero!
Cured!22 September 2016 at 7:46 am #23208”James-Freeman-facebook” wrote:The fundamental problem is that a 50% discount sounds great until you consider that the mark up is over 10,000%
The discount reduces that to a mere 5,000% and no matter which way you look at it $50,000 is a shit ton of cash for something that costs a few hundred dollars.
Gilead have been magnificent in reframing the arguments from:
1) “Greedy Pharma price gouging” to “Mean insurers refuse to pay”
2) “Prices are unaffordable” to “We give big discounts”
3) “Most of the world can’t get access” to “We have an access program for low income countries”
….Generally speaking, I see “reframing” as a technique having two facets:
– it can be used to correct a wrong understanding or provide a better clarity for an argument / situation / context / problem, etc. // not Gilead’s case
– it can be used to divert attention from a certain “sensitive” situation with the goal to either close that situation or to win additional time until a new/different context will arise/appear.Thinking on Gilead and the today’s world where people are quite well connected to the internet, I believe G’s strategy to establish an extremely high price for the HCV drugs took into account among other aspects also the following 2:
– the “20-30 years protection” given by the Patent laws will not resist in front of the generics, NOT when 200 million people are having HCV – especially that the information about the medical tourism, buyer’s clubs, news about generics are spread much much faster than 15 years ago (HIV case)
– the “reframing” techniques mentioned above allows Gilead to either stay in control of the monopoly they have, either win additional time in which they can make a lot of money and fast.Cheers,
RHF
In fiecare an HCV ucide peste 500000 oameni.Medicamentele generice pentru hepatita C functioneaza. Nu deveni statistica! Cauta pe Google “medicamente generice pentru hepatita C”.
HCV kills more than 500000 people every year. HCV generic drugs work. Don’t become a statistic.
By sharing this Youtube video you might save someone’s life!
My TX: HEPCVIR-L[generic Harvoni]-India
SVR52 achieved22 September 2016 at 2:05 pm #23214$500 a pill.
Still obscene. And still an age-old retail ploy-jack the price of an item up to ridiculous levels and then offer a “half-price” sale and make out like a bandit.
m
Curehcvnow@gmail.com
http://forums.delphiforums.com/generichcvtxG 1a F-1
Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil
11/17/15 4 wk lab ALT 17 AST 16 <15
11/18/15 Started Harvoni
12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND
1/14/16 Fin. Tx
7/07/16 UND SVR 24 -
AuthorPosts
- You must be logged in to reply to this topic.